StockNews.com Begins Coverage on Streamline Health Solutions (NASDAQ:STRM)

Stock analysts at StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRMGet Free Report) in a note issued to investors on Monday. The firm set a “sell” rating on the stock.

Streamline Health Solutions Stock Down 4.1 %

Shares of NASDAQ:STRM opened at $2.78 on Monday. The firm has a 50 day simple moving average of $2.80 and a 200 day simple moving average of $3.13. Streamline Health Solutions has a 52 week low of $1.82 and a 52 week high of $9.75. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.46 and a current ratio of 0.46. The company has a market cap of $11.88 million, a PE ratio of -1.15 and a beta of 1.78.

Streamline Health Solutions (NASDAQ:STRMGet Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported ($0.52) EPS for the quarter, missing the consensus estimate of ($0.42) by ($0.10). Streamline Health Solutions had a negative net margin of 50.51% and a negative return on equity of 56.96%. The company had revenue of $4.70 million for the quarter, compared to analysts’ expectations of $4.70 million.

About Streamline Health Solutions

(Get Free Report)

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.

Read More

Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.